Bangwei Cao Selected Research

Carcinoma (Carcinomatosis)

1/2021	Role of long non-coding RNA H19 in therapy resistance of digestive system cancers.
8/2015	Decreased expression of claudin-3 is associated with a poor prognosis and EMT in completely resected squamous cell lung carcinoma.
7/2005	LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bangwei Cao Research Topics

Disease

46	Neoplasms (Cancer) 04/2024 - 07/2005
11	Stomach Neoplasms (Stomach Cancer) 07/2023 - 02/2005
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2023 - 07/2015
8	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2017
8	Neoplasm Metastasis (Metastasis) 05/2021 - 05/2015
6	Colorectal Neoplasms (Colorectal Cancer) 03/2023 - 05/2016
6	Breast Neoplasms (Breast Cancer) 11/2021 - 10/2015
5	Adenocarcinoma 01/2023 - 01/2014
5	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 05/2018
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 01/2014
4	Esophageal Squamous Cell Carcinoma 03/2023 - 01/2013
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2023 - 05/2015
3	Infections 11/2023 - 09/2007
3	Fatigue 11/2023 - 01/2015
3	Carcinoma (Carcinomatosis) 01/2021 - 07/2005
3	Neutropenia 05/2016 - 07/2015
2	Esophageal Neoplasms (Esophageal Cancer) 05/2023 - 01/2020
2	Digestive System Neoplasms (Cancer of the Digestive System) 01/2022 - 01/2021
2	Hand-Foot Syndrome 01/2021 - 05/2016
2	Leukopenia 01/2021 - 07/2015
2	Hepatitis B 01/2021 - 11/2006
2	Triple Negative Breast Neoplasms 01/2021 - 04/2020
2	Anemia 01/2021 - 01/2015
2	Carcinogenesis 01/2015 - 01/2013
2	Lung Neoplasms (Lung Cancer) 01/2015 - 05/2012
1	Ulcerative Colitis 01/2024
1	Crohn Disease (Crohn's Disease) 01/2024
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024
1	Circulating Neoplastic Cells 01/2024
1	Tremor (Tremors) 11/2023
1	Hypopharyngeal Neoplasms 11/2023
1	Encephalitis (Encephalitis, Rasmussen) 11/2023
1	Autoimmune Diseases of the Nervous System 11/2023
1	Sarcoma (Soft Tissue Sarcoma) 03/2023
1	Rectal Neoplasms (Rectal Cancer) 01/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2013
9	apatinibIBA 01/2021 - 01/2018
8	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2020
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 04/2018
7	ErbB Receptors (EGF Receptor)IBA 12/2019 - 01/2015
5	AutoantibodiesIBA 11/2023 - 05/2015
5	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2015
5	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2018 - 01/2018
4	Tyrosine Kinase InhibitorsIBA 01/2019 - 01/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024 - 01/2018
3	CateninsIBA 05/2021 - 08/2015
3	AntigensIBA 01/2021 - 05/2015
3	Bevacizumab (Avastin)FDA Link 12/2019 - 10/2015
3	Codon (Codons)IBA 05/2012 - 07/2005
2	raltitrexed (D 1694)IBA 03/2023 - 01/2020
2	ProteomeIBA 01/2023 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 03/2022 - 07/2015
2	Cadherins (E-Cadherin)IBA 05/2021 - 08/2015
2	VimentinIBA 05/2021 - 08/2015
2	Long Noncoding RNAIBA 01/2021 - 01/2020
2	Conditioned Culture MediaIBA 01/2021 - 01/2020
2	AntibodiesIBA 01/2021 - 08/2017
2	Monoclonal AntibodiesIBA 01/2021 - 12/2019
2	Angiogenesis InhibitorsIBA 04/2020 - 01/2018
2	pyrotinibIBA 01/2020 - 01/2019
2	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 01/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2019 - 10/2015
2	Carboplatin (JM8)FDA LinkGeneric 12/2019 - 07/2015
2	Lysine (L-Lysine)FDA Link 11/2018 - 07/2005
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2018 - 07/2015
2	Polysaccharides (Glycans)IBA 04/2018 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 05/2015
2	Claudin-3IBA 01/2018 - 08/2015
2	ORALIT (ORS)IBA 05/2015 - 12/2010
2	Gemcitabine FDA Link 07/2014 - 01/2014
2	DNA (Deoxyribonucleic Acid)IBA 05/2012 - 07/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2024
1	LigandsIBA 01/2024
1	Methylprednisolone FDA LinkGeneric 11/2023
1	Immunoglobulin G (IgG)IBA 11/2023
1	camrelizumabIBA 11/2023
1	SteroidsIBA 11/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2023
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 04/2023
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2023
1	anlotinibIBA 03/2023
1	EnzymesIBA 01/2023
1	Competitive Endogenous RNAIBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	ImmunosorbentsIBA 01/2023
1	Untranslated RNA (Noncoding RNA)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2022
1	AlbuminsIBA 01/2022
1	GlobulinsIBA 01/2022
1	spleen aminopeptide oral lyophilized powderIBA 11/2021
1	sintilimabIBA 11/2021

Therapy/Procedure

20	Drug Therapy (Chemotherapy) 11/2023 - 01/2014
17	Therapeutics 01/2024 - 01/2014
6	Radiotherapy 11/2023 - 05/2016
5	Immunotherapy 04/2024 - 01/2022
1	Chemoradiotherapy 11/2023
1	Induction Chemotherapy 11/2023
1	Adjuvant Chemotherapy 07/2023